## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -3.1% below STRENGTH zone (3.0-6.0%); PEG 3.76 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($531.62)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 1)

**1. Northrop Grumman Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251203T164200 | Bullish | Relevance: 100%
- Northrop Grumman Corp. (NOC) shares rose 1.16% to $553.32 on Wednesday, outperforming the broader market during a favorable trading session. The S&P 500 Index (SPX) increased by 0.30%, and the Dow Jones Industrial Average (DJIA) rose by 0.86%. This marks the second consecutive day of gains for Northrop Grumman's stock.

**2. Analysts Offer Insights on Industrial Goods Companies: XPO (XPO), Northrop Grumman (NOC) and Quanta Services (PWR)**
- Source: The Globe and Mail | 20251203T152146 | Bullish | Relevance: 100%
- This article highlights bullish sentiments from financial analysts regarding three industrial goods companies: XPO, Northrop Grumman, and Quanta Services. Analysts from BMO Capital, Bank of America Securities, and Roth MKM have issued Buy ratings and provided price targets for these stocks, indicating potential upside from current levels. The report details the specific analyst ratings, price targets, and their professional track records.

**3. 3 Reasons to Sell NOC and 1 Stock to Buy Instead**
- Source: Finviz | 20251202T110500 | Bearish | Relevance: 100%
- This article identifies three reasons to consider selling Northrop Grumman (NOC) stock: slow organic growth suggesting waning demand, shrinking operating margins over the past five years, and declining return on invested capital (ROIC) indicating less profitable new investments. The author suggests opportunities elsewhere due to a high forward P/E and recommends looking into semiconductor stocks or StockStory's curated list of high-quality stocks.

**4. BNP Paribas Has a Positive Outlook on Northrop Grumman (NOC)**
- Source: Finviz | 20251202T013300 | Bullish | Relevance: 100%
- BNP Paribas Exane initiated coverage of Northrop Grumman (NOC) with an Outperform rating and a $710 price target. This positive analyst outlook is supported by Northrop Grumman securing a significant contract valued at up to $100 million from the United States Air Force for support services related to its Stand-in Attack Weapon (SiAW) Subsystem. The contract runs until December 2034, reinforcing the company's long-term prospects in the defense sector.

**5. BNP Paribas Has a Positive Outlook on Northrop Grumman (NOC)**
- Source: Insider Monkey | 20251202T013300 | Bullish | Relevance: 99%
- BNP Paribas initiated coverage on Northrop Grumman (NOC) with an Outperform rating and a $710 price target, highlighting it as a top industrial stock. This positive outlook is further supported by Northrop Grumman securing a $100 million contract from the U.S. Air Force for support services related to its Stand-in Attack Weapon (SiAW) Subsystem. The company, a Virginia-based global aerospace and defense firm, will perform the contracted tasks in Baltimore, Maryland, utilizing its advanced sensing and seeker manufacturing sites.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.08M) |
| Sells | 2 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.8x requires aggressive growth execution.
2. Near-term weakness: 5.6% below SMA50 despite long-term uptrend.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.76 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $82.7B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.76 |
| Forward P/E | 19.2 |
| Current P/E | 21.2 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -1.6% to -3.1% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.1pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). OFD pattern: +DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.10% (CS: 19) | Weak |
| RSI_14 | 38.3 | Neutral |
| MACD Histogram | -0.38 | Bearish |
| vs SMA20 | 0.983x | Below |
| vs SMA50 | 0.944x | Below |
| vs SMA200 | 1.032x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $553.00
- **Stop Loss:** $531.62 (3.9% risk)
- **Target:** $574.38 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 46
- **Position Value:** $25,438.00
- **Portfolio %:** 25.44%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*